Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00993291 · ClinicalTrials.gov registry record · Phase 1
Deep Brain Stimulation (DBS) Frequency Effects on Gait in Parkinson's Disease(PD)
A Phase 1 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00993291 is a Phase 1 study that has completed, run by Vanderbilt University. The registered enrollment target is 20 participants.
The verdict
NCT00993291, a Phase 1 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
In this study the investigators will evaluate the effect of both low and high frequency Deep Brain stimulation of the subthalamic nucleus (STN) in Parkinson's patients who have noted a change in their walking. The investigators' hypothesis is: 1. Stimulation at 60 Hertz (Hz) is associated with improved gait with increased stride length and faster time on the Stand walk sit test. 2. There is no worsening of the Unified Parkinson's Disease Rating Scale (UPDRS) at 60 Hz.
Interventions
- PROCEDURE Frequency change to 60 Hz
- PROCEDURE Frequency change to 130 Hz
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00993291
The ClinicalTrials.gov registry entry for NCT00993291 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Frequency change to 60 Hz is the first listed.
NCT00993291 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00993291 about?
NCT00993291 is a clinical study titled "Deep Brain Stimulation (DBS) Frequency Effects on Gait in Parkinson's Disease(PD)". In this study the investigators will evaluate the effect of both low and high frequency Deep Brain stimulation of the subthalamic nucleus (STN) in Parkinson's patients who have noted a change in their walking. The investigators' hypothesis is: 1. Stimulation at 60 Hertz (Hz) is associated with impr...
What is the current status of trial NCT00993291?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2009-11. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00993291?
The interventions under investigation include: Frequency change to 60 Hz (PROCEDURE), Frequency change to 130 Hz (PROCEDURE).
Who is sponsoring clinical trial NCT00993291?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.